Insulin Resistance and Type 2 Diabetes Mellitus

Insulin resistance is the hallmark of type 2 diabetes mellitus, where impaired insulin signaling in skeletal muscle, adipose tissue, and the liver results in hyperglycemia and metabolic imbalance. The pathogenesis involves defective insulin receptor activity, increased free fatty acids, and chronic inflammation contributing to β-cell stress and eventual dysfunction. This progression links obesity directly to type 2 diabetes development, making early detection and intervention critical. Novel biomarkers, lifestyle modifications, pharmacological agents, and emerging therapies such as incretin-based treatments are transforming management approaches to mitigate long-term complications.

    Related Conference of Insulin Resistance and Type 2 Diabetes Mellitus

    October 20-21, 2025

    25th Global Summit on Obesity

    Dubai, UAE
    March 26-27, 2026

    28th Global Obesity Meeting

    London, UK
    June 15-16, 2026

    22nd Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Insulin Resistance and Type 2 Diabetes Mellitus Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in